Home
FDA Calendar
About & More
Testimonials
Useful Links
Our Disclaimer
Updates and Roadmap
Contribute
Create Company Profile
Create Drug Profile
Browse
Contact
FDA Calendar for Nanogen, Inc. (NGEN.PK)
Login Now
|
Register (free)
Nanogen, Inc. is a diagnostics company with the mission to make the detection, the diagnosis, and the treatment and monitoring of an individual’s health easier and faster. It participates in two markets. The first is the molecular diagnostics market where the Company offers assays for real-time polymerase chain reaction (PCR) applications. Molecular diagnostics is the analysis of deoxyribonucleic acid (DNA), ribonucleic acid and proteins at the molecular level and is performed in clinical laboratories. The second is the point-of-care (POC) market where it offers rapid immunoassay tests for cardiac emergency care. In POC, the diagnostic may be performed in near patient settings, such as an emergency room or doctor’s office. Within these two markets, the Company focuses primarily on infectious disease and cardiac testing. In May 2009, the Company filed a voluntary petition under chapter 11 of title 11 of the United States Code in the Bankruptcy Court for the District of Delaware.
Around The Net
Latest News
Twitter Stream
Yahoo Message Board
Google Message Board
You are reading news provided by a variety of web sources.
Drug Pipeline
Drug Name
Type Of Drug
FDA Status
Drug Phase
This company currently does not have any drugs. If you would like to create one please
click here
.
Events
No future events listed at this time, please check back later.
Outcome
Past Events
Add New Event
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Event
Important Links
No links found.
Add New Link
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Link
NGEN.PK
$0.00
0.00 0.00%
2/3/2012 2:24:00 PM
Sponsors
Other Links
Corporate Website
Analyst Estimates (MarketWatch)
CNN Money
Google Finance
Guru Focus
Major Holders
MSN Money
SEC Filings (EDGAR Online)
Seeking Alpha
Yahoo! Finance